Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Compl... (ts in September 2005 and it is currently...)

Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions

Date:10/22/2007

ts in September 2005, and it is currently the market- leading drug-eluting stent outside the United States excluding Japan (the TAXUS Liberte stent is not available for sale in Japan). The Company received CE Mark for the TAXUS Liberte Long Stent in May 2007. The TAXUS Liberte Stent and the TAXUS Express 2.25 mm Stent are currently pending approval by the U.S. Food and Drug Administration and are limited by federal law to investigational use and not available for sale in the United States. The Company plans to launch the TAXUS Liberte Stent in the United States in 2008.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, product performance and competitive offerings. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
4. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
5. To Stent or Not: Is That the Question?
6. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
9. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
11. Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007

Post Your Comments:

(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...

(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...

(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... author has released its latest research ...

[0] Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile [0] Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard [0] Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... sustained levels of drug reported after one treatmentLOUISVILLE, ... held biotechnology company developing medicines for the treatment ... it successfully completed its Phase I ASaP (Assessment ... with Neovascular Age-Related Macular Degeneration) clinical trial for ...

... Up To $55 Million in Near Term Payments ... today announced that the company has entered into ... European rights to develop and commercialize the investigational ... syndrome with constipation (IBS-C) and other gastrointestinal conditions. ...

Other Medicine Technology:Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 2 Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II 3 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 2 Ironwood Announces Linaclotide European Licensing Agreement with Almirall 3

Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II Ironwood Announces Linaclotide European Licensing Agreement with Almirall

(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...

(Date:12/15/2009)... Austrian researchers have successfully developed a new electrophoretic ... in the blood. The technique, using SARCOSYL-PAGE, ... not alter the performance characteristics of SDS-PAGE for ... funded by a grant from the World Anti-Doping ... Drug Testing and Analysis published by ...

(Date:12/15/2009)... Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization of technologies ... resolutions that the Company had proposed at the Annual General Meeting of Shareholders held on ... Votes ... Non-, Matter ... For Against ...

(Date:12/15/2009)... of America and the Saint Thomas, Lupus Trust ... son of the legendary John Lennon, and James Scott ... raise funds for research on the disease lupus. From ... proceeds from downloading "LUCY" at iTunes will be donated ... Saint Thomas, Lupus Trust in Great Britain. ,, Both ...

(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...

Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2 Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3 Health News:Researchers discover novel method for detecting MIRCERA 2 Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2 Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3 Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2 Health News:Fat Hormone May Protect Against Alzheimer's 2 Health News:Fat Hormone May Protect Against Alzheimer's 3

[0] Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil [1] Researchers discover novel method for detecting MIRCERA [1] Senetek PLC Announces 2009 Annual General Meeting Voting Results [0] Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research [0] Fat Hormone May Protect Against Alzheimer's

... NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ), a leading ... States, today announced that,it will host a conference call ... management to review the company,s third quarter results. ... conference call will be held on Wednesday, October,31, 2007 ...

... Injustice, Will Challenge,Corporate-Backed Proponents of "Health Courts", ... Nance, co-author of the groundbreaking new report on ... featured speakers at a,patient safety forum in Cheyenne, ... the merits and weaknesses of the health courts ...

... http://www.medikeeper.com ), a leading provider of technology solutions ... Series A investment round,led by Hawaii-based venture capital ... by a team of entrepreneurs and medical,professionals with ... accessible online. Beginning with its flagship Personal Health ...

... New T-Shirt Design Marks 2007 Race in San Diego, ... Komen San,Diego Race for the Cure(R) will be held in ... than three weeks until the Race, participants still,have two final ... http://www.komensandiego.org until Monday, October 22 or visit,Roadrunner Sports at ...

... Massachusetts,is not a model for California health reform, according ... to buy private health coverage.,Coverage in Massachusetts is already ... not capped or regulated, have indicated rates,will increase again ... Massachusetts law, which provides an,overview of the cost and ...

... the drugs are used with certain painkillers, study finds ... called selective serotonin reuptake inhibitors (SSRIs), which include Celexa, ... gastrointestinal bleeding, and the threat is more than six ... medications at the same time as SSRIs, a new ...

Other Medicine News:Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2 Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2 Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2 Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 2 Health News:Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park 3 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 2 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 3 Health News:Massachusetts Mandatory Health Insurance Purchase Law is No Model for California 4 Health News:Antidepressants Boost GI Bleeding Risk 2

NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor Susan G. Komen Race(R) for the Cure Set for November 4 in Balboa Park Massachusetts Mandatory Health Insurance Purchase Law is No Model for California Antidepressants Boost GI Bleeding Risk

Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat...

... Topical Anesthetic, ,Designed for adolescent ... incorporates an additional lumen and injection ... anesthetic above and below the cuff., ... designs which allow for CO2 monitoring, ...

Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....

SHERIDAN PREFORMED Endotracheal Tubes are designed to conveniently position the anesthesia circuit out of the surgical field for oral and maxillofacial procedures....

Medicine Products:

Left Carlens Carina Hook SHERIDAN LITA Cuffed Endotracheal Tube SHERIDAN LAR-A-JECT® Reinforced Laryngectomy Tubes SHERIDAN PREFORMED Oral Endotracheal Tubes

Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Compl...(ts in September 2005 and it is currently...),Health